A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis.
Lebwohl
M
M
Department of Dermatology, Mount Sinai School of Medicine, New York, NY, USA.
Siskin
S B
SB
Epinette
W
W
Breneman
D
D
Funicella
T
T
Kalb
R
R
Moore
J
J
D000279:Administration, Cutaneous; D000328:Adult; D002117:Calcitriol / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002990:Clobetasol / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008297:Male; D009824:Ointments; D011565:Psoriasis / Q000188:drug therapy*; D012074:Remission Induction; D014662:Vasoconstrictor Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D003879:Dermatologic Agents; D004338:Drug Combinations; D009824:Ointments; D014662:Vasoconstrictor Agents; C055085:calcipotriene; C064466:halobetasol; D002990:Clobetasol; D002117:Calcitriol